100 MG Imatinib Mesylate Tablets
100 MG Imatinib Mesylate Tablets

100 MG Imatinib Mesylate Tablets

MOQ : 100 Packs

100 MG Imatinib Mesylate Tablets Specification

  • Indication
  • Used in the treatment of chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GIST), and other specific types of cancer.
  • Dosage Form
  • Tablet
  • Salt Composition
  • Imatinib Mesylate 100 mg
  • Feature
  • High purity, suitable for oral administration, provided in blister packs
  • Ingredients
  • Imatinib Mesylate, Excipients Q.S.
  • Application
  • Oncology
  • Physical Color/Texture
  • Light yellow to brownish-orange, film-coated tablet
  • Fermentation Smell
  • Odorless
  • Storage Instructions
  • Store at a temperature below 30C, protect from moisture and light.
  • Shelf Life
  • 24 to 36 months from the date of manufacture
  • Potential Side Effects
  • Nausea, fluid retention, muscle cramps, rash, fatigue (refer to pack insert for full guidance)
  • Packaging Size
  • 10 tablets per strip, commonly supplied in boxes
  • ATC Code
  • L01EA01
  • Strength
  • 100 mg
  • Regulatory Approval
  • Manufactured according to applicable regulatory standards (e.g., WHO-GMP certified plant)
  • Prescription Status
  • Prescription only medicine
  • Packing Type
  • Blister strips in cartons
  • Administration Route
  • Oral
  • Batch Number and Expiry Details
  • Printed on individual packs
  • Intended User
  • Adults and pediatric patients as per physician's advice
  • Brand Name
  • Imatinib Mesylate Tablets
 

100 MG Imatinib Mesylate Tablets Trade Information

  • Minimum Order Quantity
  • 100 Packs
  • Payment Terms
  • Cash in Advance (CID)
  • Supply Ability
  • 5000 Packs Per Month
  • Delivery Time
  • 10 Days
  • Main Domestic Market
  • All India
 

About 100 MG Imatinib Mesylate Tablets



Discover the venerable Imatinib Mesylate Tablets 100 MG, engineered with high purity for reliable oral oncology treatment. Each gorgeous light yellow to brownish-orange, film-coated tablet is nobly crafted and supplied affordably in tamper-proof blister strips within cartons. With regulatory approval and manufacturing in WHO-GMP certified plants, every batch ensures optimal quality. Limited time offer-order today to access this prescription-only medicine for adults and pediatric patients as advised by physicians. Batch number and expiry are printed for traceability. Efficacy meets elegance-experience confidence with every dose.

Applications and Usage: Imatinib Mesylate 100 MG Tablets

Designed for both adults and pediatric patients, this prescription-only tablet offers a valuable option for those undergoing treatment for chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GIST), and certain other cancers. The oral administration route ensures convenient usage, guided by physician advice. Whether in clinical practice or specialized oncology care, Imatinib Mesylate Tablets integrate seamlessly into comprehensive treatment regimens. Each dose provides reliability, serving as a trusted ally in advanced cancer management.


Export and Domestic Supply: Imatinib Mesylate Tablets Distribution

Imatinib Mesylate Tablets 100 MG are shipped goods reaching diverse export markets, including several key regions and countries outside India, utilizing efficient transport services. The product is also distributed extensively within the main domestic market of India. We offer samples under transparent sample policies to establish trust and effectiveness. Both international and domestic clients benefit from responsive customer service and seamless logistics, ensuring timely delivery and adherence to quality standards in every shipment.


FAQ's of 100 MG Imatinib Mesylate Tablets:


Q: How should Imatinib Mesylate Tablets 100 MG be stored for optimal efficacy?

A: It is recommended to store the tablets below 30C, protecting them from moisture and light, to maintain their potency throughout their shelf life of 24 to 36 months.

Q: What is the primary medical use of Imatinib Mesylate Tablets 100 MG?

A: These tablets are indicated mainly for the treatment of chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GIST), and certain other cancers as prescribed by a physician.

Q: When should I take Imatinib Mesylate Tablets, and how do I ensure correct usage?

A: Always follow your physician's advice regarding dosage and schedule. These tablets are for oral administration and should be used as part of a specific treatment plan tailored to your needs.

Q: Where can I find details about batch number, expiry, and safety guidelines for these tablets?

A: Batch number and expiry details are printed on individual packs. Comprehensive safety guidelines and potential side effects can be found in the pack insert provided with each carton.

Q: What are the potential side effects of using Imatinib Mesylate Tablets 100 MG?

A: Some of the potential side effects include nausea, fluid retention, muscle cramps, rash, and fatigue. Please refer to the pack insert for full information and consult your physician if any adverse reactions occur.

Q: How do you ensure the quality and regulatory compliance of Imatinib Mesylate Tablets?

A: Our tablets are manufactured in WHO-GMP certified plants, adhering strictly to applicable regulatory standards to guarantee quality, purity, and safety in every batch supplied.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti-Cancer Medicine Category

395 MG Pembrolizumab And Berahyaluronidase Alfa Injection

395 MG Pembrolizumab And Berahyaluronidase Alfa Injection

Minimum Order Quantity : 100 Packs

Dosage Form : Injection

Indication : Treatment of certain cancers including melanoma, nonsmall cell lung cancer, and others as determined by a healthcare professional

Physical Color/Texture : Other , Clear to slightly opalescent, colorless to pale yellow solution

Ingredients : Other , Pembrolizumab, Berahyaluronidase alfa, excipients, sterile water for injection

400 MG Daratumumab Concentrate For Solution For Infusion

400 MG Daratumumab Concentrate For Solution For Infusion

Price 45000 INR / Vial

Minimum Order Quantity : 100 Vials

Dosage Form : Concentrate For Solution For Infusion

Indication : Multiple myeloma (treatment of adult patients with multiple myeloma)

Physical Color/Texture : Other , Clear to opalescent, colorless to slightly yellow solution

Ingredients : Other

Nivolumab Injection

Nivolumab Injection

Price 90000 INR / Vial

Minimum Order Quantity : 100 Vials

Dosage Form : Injection

Indication : Treatment of advanced melanoma, nonsmall cell lung cancer, renal cell carcinoma, classical Hodgkin lymphoma, squamous cell carcinoma of the head and neck, urothelial carcinoma and other cancers.

Physical Color/Texture : Other , Clear to slightly opalescent, colorless to pale yellow solution

Ingredients : Other

50 MG Pembrolizumab For Injection

50 MG Pembrolizumab For Injection

Minimum Order Quantity : 100 Packs

Dosage Form : Lyophilized Powder for Injection

Indication : Used in the treatment of certain cancers such as melanoma, nonsmall cell lung cancer, head and neck cancer, classical Hodgkin lymphoma, and urothelial carcinoma

Physical Color/Texture : Other , White to offwhite lyophilized powder

Ingredients : Other , Pembrolizumab and excipients



Back to top